Toxikon Corporation

Toxikon Corporation has been working with the pharmaceutical, biotechnology, and medical device industry for nearly 40 years. Toxikon is a Contract Research Organization (CRO), with ISO/IEC 17025 accreditation that is registered with the US FDA and Japanese MHLW for drug and medical device testing. The Company provides in vivo, analytical, and in vitro testing services. Toxikon’s safety services include toxicology (acute, subchronic, and chronic toxicity, reproductive toxicity, genetic toxicology, carcinogenicity), pharmacokinetics, toxicokinetics, bioavailability, ADME, chemical characterization, impurities analysis and synthesis, bioanalytical, and microbiology.

Toxikon has two primary locations: headquartered in Bedford, MA within a multi building campus, including 117,000 square feet of state-of-the art facilities and an additional 20,000 square foot European lab operation in Leuven, Belgium. Toxikon’s laboratory facilities are fully accredited including GLP/GMP registrations, and the Bedford facilities have full USDA, OLAW, and AAALAC animal testing credentials. In addition, both facilities are ISO accredited, enabling GLP and non-GLP work across both facilities. The Company currently has approximately 80 animal rooms, and has extensive and fully equipped surgical suites, along with support services that include efficacy and research services, and histology and clinical pathology. The Company currently serves over 1,000 active customers across the pharmaceutical, biotechnology and medical device sectors through-out the world.

To learn more, please visit www.toxikon.com or contact info@toxikon.com.